FindMyKOL
Clinical trialNCT05842512RecruitingPhase 2Interventional

Study of ADI-PEG 20 Versus Placebo in Subjects With NASH

SponsorPolaris GroupEnrollment60Nonalcoholic Steatohepatitis (NASH)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Evaluate efficacy and safety of ADI-PEG 20 in patients with NASH
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Taiwan
  • Ditmanson Medical Foundation Chiayi Christian Hospital；chiayi Christian Hospital (cych)

    Chiayi City, Taiwan, Taiwan

    Recruiting
  • Chang Gung Medical Foundation-Kaohsiung (cgmf-Ks)

    Kaohsiung, Taiwan, Taiwan

    Recruiting
  • E-Da Hospital (edh)

    Kaohsiung, Taiwan, Taiwan

    Recruiting
  • Kaohsiung Medical University Chung-Ho Memorial Hospital(kmuh)

    Kaohsiung, Taiwan, Taiwan

    Recruiting
  • Chang Gung Medical Foundation-Keelung (cgmf-Kl)

    Keelung, Taiwan, Taiwan

    Recruiting
  • National Cheng Kung University Hospital (nckuh)

    Tainan, Taiwan, Taiwan

    Recruiting
  • Fu Jen Catholic University Hospital (fjcuh)

    Taipei, Taiwan, Taiwan

    Recruiting
  • National Taiwan University Hospital (ntuh)

    Taipei, Taiwan, Taiwan

    Recruiting
  • Taipei Veterans General Hospital (tpvgh)

    Taipei, Taiwan, Taiwan

    Recruiting
  • Chang Gung Medical Foundation-Linkou (cgmf-Lk)

    Taoyuan, Taiwan, Taiwan

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Pegargiminase
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Sept 2023
Primary completion
31 Dec 2027
Completion
31 Jan 2028
Last update posted
23 Sept 2025
Registered enrollment
60
Registry id
NCT05842512
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.